Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis

Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis

Guardado en:
Detalles Bibliográficos
Autores principales: Elmira R. Vagapova, Timofey D. Lebedev, Vladimir S. Prassolov
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/29bbb599cea84f50b7afcfcbd775548f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:29bbb599cea84f50b7afcfcbd775548f
record_format dspace
spelling oai:doaj.org-article:29bbb599cea84f50b7afcfcbd775548f2021-12-02T16:37:37ZPublisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis10.1038/s41598-021-97281-92045-2322https://doaj.org/article/29bbb599cea84f50b7afcfcbd775548f2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97281-9https://doaj.org/toc/2045-2322Elmira R. VagapovaTimofey D. LebedevVladimir S. PrassolovNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Elmira R. Vagapova
Timofey D. Lebedev
Vladimir S. Prassolov
Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
format article
author Elmira R. Vagapova
Timofey D. Lebedev
Vladimir S. Prassolov
author_facet Elmira R. Vagapova
Timofey D. Lebedev
Vladimir S. Prassolov
author_sort Elmira R. Vagapova
title Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
title_short Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
title_full Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
title_fullStr Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
title_full_unstemmed Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
title_sort publisher correction: viral fibrotic scoring and drug screen based on mapk activity uncovers egfr as a key regulator of covid-19 fibrosis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/29bbb599cea84f50b7afcfcbd775548f
work_keys_str_mv AT elmirarvagapova publishercorrectionviralfibroticscoringanddrugscreenbasedonmapkactivityuncoversegfrasakeyregulatorofcovid19fibrosis
AT timofeydlebedev publishercorrectionviralfibroticscoringanddrugscreenbasedonmapkactivityuncoversegfrasakeyregulatorofcovid19fibrosis
AT vladimirsprassolov publishercorrectionviralfibroticscoringanddrugscreenbasedonmapkactivityuncoversegfrasakeyregulatorofcovid19fibrosis
_version_ 1718383620765253632

Ejemplares similares